Previous 10 | Next 10 |
home / stock / bayzf / bayzf news
Bayer is still in a downtrend with the legal battle going on and a settlement still unclear. However, the company could report strong growth in the second quarter and increased its guidance for fiscal 2021. The stock seems to be at a strong support level and is still undervalued. ...
Regeneron Pharmaceuticals (NASDAQ:REGN) announces that an ongoing Phase 2 trial evaluating an 8 mg dose of aflibercept met its primary safety endpoint, with no new safety signals observed compared to the currently-approved 2 mg dose of EYLEA (aflibercept) Injection in patients with wet a...
Bayer (OTCPK:BAYRY -0.5%) says it has filed a petition to the U.S. Supreme Court to review and reverse court verdicts that awarded damages in which a plaintiff said Monsanto's Roundup weedkiller caused cancer. The case concerns a California resident who said his lymphoma was caused by the com...
Bayer Aktiengesellschaft (BAYZF) Q2 2021 Earnings Conference Call August 5, 2021 8:00 AM ET Company Participants Oliver Maier - Head-Investor Relations Werner Baumann - Chief Executive Officer Wolfgang Nickl - Chief Financial Officer Stefan Oelrich - President-Pharmaceuticals Division Liam Co...
The following slide deck was published by Bayer Aktiengesellschaft in conjunction with their 2021 Q2 earnings call. For further details see: Bayer Aktiengesellschaft 2021 Q2 - Results - Earnings Call Presentation
Bayer AG (OTCPK:BAYZF): Q2 Non-GAAP EPS of €1.59; GAAP EPS of -€9.79. Revenue of €10.85B (+8.0% Y/Y) FY21 Guidance: The company now expect to generate sales of approximately €43 billion (previously: approximately €41 billion). This now corresponds to an...
The stock market continued to perform well with the S&P 500 up another 2.27% bringing its YTD gains to almost exactly 17%. I am continuing my monthly investment plans while still awaiting a market correction or possibly a real crash once market euphoria has come down. My divid...
Bayer (OTCPK:BAYZF) said Thursday it would add an extra provision of $4.5B to deal with lawsuits alleging that its weedkiller Roundup can cause cancer, Reuters reported. While thousands of users have claimed Roundup, a brand acquired by the company as part of its $63B acquisition of...
Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may be worth your time for further analy...
In this commentary, I’ll cover Oakmark’s thoughts on governance in relation to our Funds’ selection of undervalued stocks. Governance is a back-burner issue for investors who trade their portfolios frequently. When you only hold a stock for a few months, it barely...
News, Short Squeeze, Breakout and More Instantly...
Bayer AG Registered Shares Company Name:
BAYZF Stock Symbol:
OTCMKTS Market:
NORTHAMPTON, MA / ACCESSWIRE / August 29, 2023 / Bayer - As climate change quickens, societal expectations increase and the threat of resistance grows, new crop protection solutions are imperative. Advances in the life sciences and data-driven technologies hold the key to expanding our pipeline ...
Monsanto Must Face Georgia State Jurors in Lawsuit Over Cancer-Causing Roundup Herbicide PR Newswire 11th Circuit opinion finds chemical giant subject to state's warning label laws Nachawati Law Group trial lawyers gearing up for next Roundup cancer trial in Au...
Bayer Runs Out of Appeals at US Supreme Court as Thousands of Cancer Lawsuits Await over Roundup Herbicide PR Newswire Fears Nachawati trial lawyers gearing up for next Roundup cancer trial in August WASHINGTON , June 22, 2022 /PRNewswire/ -- Baye...